Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE CELIN-BOZIER : revenue, balance sheet and financial ratios

PHARMACIE CELIN-BOZIER is a French company founded 15 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SCAER (29390), this company of category PME shows in 2024 a net income positive of 237 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE CELIN-BOZIER (SIREN 527978316)
Indicator 2024 2023 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C N/C
Net income 236 681 € 245 445 € 222 754 € 228 598 € 288 867 € 302 819 € 75 539 € 127 661 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, PHARMACIE CELIN-BOZIER generates positive net income of 237 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 128 k€ -> 237 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

236 681 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 163%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 36%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

162.609%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

35.573%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

16.9%

Solvency indicators evolution
PHARMACIE CELIN-BOZIER

Sector positioning

Debt ratio
162.61 2024
2021
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average +23 pts over 3 years

In 2024, the debt ratio of PHARMACIE CELIN-BOZIER (162.61) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
35.57% 2024
2021
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average -20 pts over 3 years

In 2024, the financial autonomy of PHARMACIE CELIN-BOZIER (35.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 284.19. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

284.19

Liquidity indicators evolution
PHARMACIE CELIN-BOZIER

Sector positioning

Liquidity ratio
284.19 2024
2021
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent +5 pts over 3 years

In 2024, the liquidity ratio of PHARMACIE CELIN-BOZIER (284.19) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of PHARMACIE CELIN-BOZIER in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE CELIN-BOZIER is estimated at 3 304 241 € (range 2 301 021€ - 4 943 334€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
2301k€ 3304k€ 4943k€
3 304 241 € Range: 2 301 021€ - 4 943 334€
NAF 5 année 2024

Valuation method used

Net Income Multiple
236 681 € × 14.0x = 3 304 242 €
Range: 2 301 022€ - 4 943 335€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE CELIN-BOZIER with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE CELIN-BOZIER

What is the revenue of PHARMACIE CELIN-BOZIER ?

The revenue of PHARMACIE CELIN-BOZIER is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE CELIN-BOZIER profitable?

Yes, PHARMACIE CELIN-BOZIER generated a net profit of 237 k€ in 2024.

Where is the headquarters of PHARMACIE CELIN-BOZIER ?

The headquarters of PHARMACIE CELIN-BOZIER is located in SCAER (29390), in the department Finistere.

Where to find the tax return of PHARMACIE CELIN-BOZIER ?

The tax return of PHARMACIE CELIN-BOZIER is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE CELIN-BOZIER operate?

PHARMACIE CELIN-BOZIER operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.